Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenana Al Adem

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Protein Science : a Publication of the Protein Society|April 13, 2023
Structural polymorphism and cytotoxicity of brain-derived β-amyloid extractsKenana Al Adem, Sungmun Lee
Pharmaceuticals (Basel, Switzerland)|December 11, 2020
Inhibition of SARS-CoV-2 Entry into Host Cells Using Small MoleculesKenana Al Adem, Aya Shanti, Cesare Stefanini, et al.
Scientific Reports|March 30, 2022
Hydrogen phosphate selectively induces MDA MB 231 triple negative breast cancer cell death in vitroAya Shanti, Kenana Al Adem, Cesare Stefanini, et al.
International Journal of Biological Macromolecules|February 1, 2020
Inhibition of lysozyme aggregation and cellular toxicity by organic acids at acidic and physiological pH conditionsKenana Al Adem, Suryani Lukman, Tae-Yeon Kim, et al.
The Journal of Biological Chemistry|December 12, 2022
pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activityKenana Al Adem, Juliana C Ferreira, Samar Fadl, et al.
Scientific Reports|March 22, 2020
Aggregation and Cellular Toxicity of Pathogenic or Non-pathogenic ProteinsSungmun Lee, Myung Chul Choi, Kenana Al Adem, et al.
ACS Omega|July 22, 2024
Inhibition of the Early-Stage Cross-Amyloid Aggregation of Amyloid-β and IAPP via EGCG: Insights from Molecular Dynamics SimulationsAmit Srivastava, Kenana Al Adem, Aya Shanti, et al.
The Biochemical Journal|May 31, 2023
Key Allosteric and Active Site Residues of SARS-CoV-2 3CLpro Are Promising Drug TargetsKenana Al Adem, Juliana C Ferreira, Samar Fadl, et al.
The Journal of Biological Chemistry|September 29, 2024
Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antiviralsJuliana C Ferreira, Adrian J Villanueva, Kenana Al Adem, et al.
Journal of Structural Biology: X|November 19, 2025
Residues of the ribose binding site are required for human ribokinase activityJuliana C Ferreira, Lyudmila Nedyalkova, Adrian J Villanueva, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Protein Science : a Publication of the Protein Society|April 13, 2023
Structural polymorphism and cytotoxicity of brain-derived β-amyloid extractsKenana Al Adem, Sungmun Lee
Pharmaceuticals (Basel, Switzerland)|December 11, 2020
Inhibition of SARS-CoV-2 Entry into Host Cells Using Small MoleculesKenana Al Adem, Aya Shanti, Cesare Stefanini, et al.
Scientific Reports|March 30, 2022
Hydrogen phosphate selectively induces MDA MB 231 triple negative breast cancer cell death in vitroAya Shanti, Kenana Al Adem, Cesare Stefanini, et al.
International Journal of Biological Macromolecules|February 1, 2020
Inhibition of lysozyme aggregation and cellular toxicity by organic acids at acidic and physiological pH conditionsKenana Al Adem, Suryani Lukman, Tae-Yeon Kim, et al.
The Journal of Biological Chemistry|December 12, 2022
pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activityKenana Al Adem, Juliana C Ferreira, Samar Fadl, et al.
Scientific Reports|March 22, 2020
Aggregation and Cellular Toxicity of Pathogenic or Non-pathogenic ProteinsSungmun Lee, Myung Chul Choi, Kenana Al Adem, et al.
ACS Omega|July 22, 2024
Inhibition of the Early-Stage Cross-Amyloid Aggregation of Amyloid-β and IAPP via EGCG: Insights from Molecular Dynamics SimulationsAmit Srivastava, Kenana Al Adem, Aya Shanti, et al.
The Biochemical Journal|May 31, 2023
Key Allosteric and Active Site Residues of SARS-CoV-2 3CLpro Are Promising Drug TargetsKenana Al Adem, Juliana C Ferreira, Samar Fadl, et al.
The Journal of Biological Chemistry|September 29, 2024
Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antiviralsJuliana C Ferreira, Adrian J Villanueva, Kenana Al Adem, et al.
Journal of Structural Biology: X|November 19, 2025
Residues of the ribose binding site are required for human ribokinase activityJuliana C Ferreira, Lyudmila Nedyalkova, Adrian J Villanueva, et al.
Pageof 2